Goldman Jonathan's Form 4 filing
Avalo Therapeutics, Inc. (AVTX) · filed Nov 17, 2025
- Accession no.
- 0002013869-25-000002
- Filed
- Nov 17, 2025
- Trade date
- Nov 14, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $163.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldman JonathanCIK 0002013869 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Common Stock | SSaleDisposed | −3,167 | $14.30 | −$45,288.1 | 0 | Direct | |
| Nov 14, 2025 | Common Stock | MOption exerciseAcquired | +8,200 | $9.88 | +$81,016 | 8,200 | Direct | |
| Nov 14, 2025 | Common Stock | SSaleDisposed | −8,200 | $14.35 | −$117,670 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Common Stock | MOption exerciseDisposed | −8,200 | $0.00 | $0 | 16,400 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.